Elmira Khabusheva to Pyrimidines
This is a "connection" page, showing publications Elmira Khabusheva has written about Pyrimidines.
Connection Strength
0.755
-
Can Ruxolitinib Crash TET2- and IDH2-Driven Clonal Hematopoiesis? Cancer Discov. 2024 Oct 04; 14(10):1768-1770.
Score: 0.716
-
Identification of cell type-specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors. J Biol Chem. 2022 08; 298(8):102226.
Score: 0.038